Ongoing research on NF2 focuses on understanding the molecular mechanisms underlying tumor development and exploring targeted therapies. Studies are investigating the role of Merlin in cell signaling pathways, and clinical trials are testing new drugs that may inhibit tumor growth by targeting specific molecular pathways. Additionally, researchers are exploring gene therapy as a potential approach to correct the underlying genetic defect in NF2.